Skip to content
sahil.science
Questions
Papers
Topics
Syntheses
Almanac
About
C⁶
2026
← Questions
Source-derived question
How did imatinib target BCR-ABL without the broad toxicity of conventional chemotherapy?
Targeted Cancer Therapy
Sources that address it
Lasker Award (Clinical Medical Research)
almanac
Related questions
How did checkpoint inhibitor drugs change outcomes for patients with metastatic melanoma?
How did imatinib change the survival outlook for patients with chronic myelogenous leukaemia?
How did this 2013 breakthrough connect to the 2018 Nobel Prize awarded to Allison and Honjo?
How did this reframing of cancer as an internal malfunction change how targeted cancer therapies are designed?
How do modern vaccines and targeted cancer therapies draw on both Mechnikov's and Ehrlich's discoveries?
How do the CTLA-4 and PD-1 checkpoints let tumours suppress an immune attack?
How does fusing a spleen cell with a myeloma cell produce a hybridoma that manufactures one antibody forever?
How does the Y-shaped antibody model inform the design of modern monoclonal antibody drugs?